[HTML][HTML] Challenges in paragangliomas and pheochromocytomas: from histology to molecular immunohistochemistry

CC Juhlin - Endocrine pathology, 2021 - Springer
Abdominal paragangliomas and pheochromocytomas (PPGLs) are rare neuroendocrine
tumors of the infradiaphragmatic paraganglia and adrenal medulla, respectively. Although …

[HTML][HTML] The value of histological algorithms to predict the malignancy potential of pheochromocytomas and abdominal paragangliomas—A meta-analysis and …

A Stenman, J Zedenius, CC Juhlin - Cancers, 2019 - mdpi.com
Pheochromocytomas (PCCs) and abdominal paragangliomas (PGLs), collectively
abbreviated PPGLs, are neuroendocrine tumors of the adrenal medulla and paraganglia …

IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer

H Liang, T Li, X Fang, Z Xing, S Zhang, L Shi, W Li… - Cancer Letters, 2021 - Elsevier
Abstract Indoleamine 2, 3-dioxygenase 1 (IDO1) catalyzing the conversion of tryptophan
(Trp) to kynurenine (Kyn) in kynurenine pathway (KP) is involved in the immunosuppression …

COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in …

C Pierre, M Agopiantz, L Brunaud, SF Battaglia-Hsu… - Virchows Archiv, 2019 - Springer
Current histoprognostic parameters and prognostic scores used in paragangliomas and
pheochromocytomas do not adequately predict the risk of metastastic progression and …

[HTML][HTML] The systems of metastatic potential prediction in pheochromocytoma and paraganglioma

Y Wang, M Li, H Deng, Y Pang, L Liu… - American journal of …, 2020 - ncbi.nlm.nih.gov
Pheochromocytoma and paraganglioma (PPGL) are rare neuroendocrine tumors that
arising from the adrenal medulla or extra-adrenal autonomic ganglia. Traditionally, PPGL …

[HTML][HTML] Molecular classification and tumor microenvironment characteristics in pheochromocytomas

S Qin, Y Xu, S Yu, W Han, S Fan, W Ai, K Zhang… - Elife, 2024 - elifesciences.org
Pheochromocytomas (PCCs) are rare neuroendocrine tumors that originate from chromaffin
cells in the adrenal gland. However, the cellular molecular characteristics and immune …

Advances in adrenal and extra-adrenal paraganglioma: practical synopsis for pathologists

CC Juhlin, O Mete - Advances in Anatomic Pathology, 2023 - journals.lww.com
Abstract Adrenal paraganglioma (or “pheochromocytoma”) and extra-adrenal
paraganglioma, collectively abbreviated PPGL, are rare but spectacular nonepithelial …

[HTML][HTML] Diagnosis for pheochromocytoma and paraganglioma: a joint position statement of the Korean Pheochromocytoma and Paraganglioma Task Force

EJ Ku, KJ Kim, JH Kim, MK Kim… - Endocrinology and …, 2021 - synapse.koreamed.org
Pheochromocytoma and paraganglioma (PPGLs) are rare catecholamine-secreting
neuroendocrine tumors but can be life-threatening. Although most PPGLs are benign …

[HTML][HTML] Histopathological analysis of tumor microenvironment and angiogenesis in pheochromocytoma

X Gao, Y Yamazaki, A Pecori, Y Tezuka… - Frontiers in …, 2020 - frontiersin.org
Pheochromocytomas (PHEOs) are relatively rare catecholamine-producing tumors derived
from adrenal medulla. Tumor microenvironment (TME) including neoangiogenesis has been …

[HTML][HTML] Recent advances in histopathological and molecular diagnosis in pheochromocytoma and paraganglioma: challenges for predicting metastasis in individual …

Y Yamazaki, X Gao, A Pecori, Y Nakamura… - Frontiers in …, 2020 - frontiersin.org
Pheochromocytomas and paragangliomas (PHEO/PGL) are rare but occasionally life-
threatening neoplasms, and are potentially malignant according to WHO classification in …